Market Access & HEOR Vendors
Consultancies for pricing, payer strategy, value & evidence, health economics and outcomes research.
39 vendors profiled
Not sure who fits? Get a curated shortlist →-
Washington, DC
Washington DC-based commercial strategy and policy consultancy serving life sciences and healthcare clients since 2013. Combines market access, reimbursement, and policy expertise with data-informed commercialization advice.
- Market access strategy
- Reimbursement & coding strategy
- Health policy analysis
- Commercialization strategy
-
Chapel Hill, NC
Digital-forward market access agency and consultancy combining first-hand industry and payer experience with digital solutions to support value communication and access strategy for life sciences companies.
- Strategic market access consulting
- HEOR/MA consulting
- Digital access solutions
- Evidence-based consulting
-
Framingham, MA
International healthcare advisory and CRO firm founded in 1999, headquartered in Framingham, MA, whose market access team covers global pricing and reimbursement, health economics, and real-world evidence.
- Global market access strategy
- Pricing & reimbursement
- Health economics
- RWE
- Transaction advisory
-
One of the largest economics consulting firms (founded 1981), with a dedicated HEOR, epidemiology, and market access practice supporting pharmaceutical products throughout their lifecycles with economic modeling and evidence strategy.
- HEOR strategy & studies
- Cost-effectiveness & budget impact models
- Epidemiology & biostatistics
- Value evidence for payers
-
Consultancy helping pharma and biotech companies design distribution, pharmacy, and patient access strategies, working closely with market access and trade & distribution teams. Part of the Omnicom Health market access ecosystem.
- Distribution & channel strategy
- Specialty pharmacy strategy
- Patient access programs
- Trade strategy
-
Washington, DC
Washington DC-based healthcare advisory firm founded in 2000 by Dan Mendelson, known for policy, reimbursement, and market access strategy for life sciences companies and health plans. Particularly strong on CMS, Medicare, Medicaid, and 340B policy.
- Healthcare policy analysis
- Reimbursement & market access strategy
- HEOR
- Value-based care consulting
- Data analytics
-
Philadelphia, PA (IntegriChain)
Management consulting firm focused on therapy commercialization strategy — market access, channel and distribution, GTN optimization, and patient services — acquired by IntegriChain in January 2022 and operating as its advisory division.
- Market access strategy
- Channel & distribution strategy
- GTN optimization
- Commercialization strategy
-
San Francisco, CA
Life sciences management consultancy founded in 2012, advising biopharma across the product and company value chain, including pricing, market access, and launch strategy, with particular depth in oncology and rare disease.
- Market access strategy
- Pricing strategy
- Launch strategy
- Portfolio & franchise strategy
-
Conshohocken, PA
Cencora's commercialization consulting arm (legacy Xcenda brand) provides market access strategy, HEOR, value and access communications, and payer engagement. Long regarded as the leader in AMCP Format formulary dossier development.
- AMCP formulary dossiers
- Global value dossiers
- HEOR
- Payer strategy & engagement
- Reimbursement & channel strategy
-
Radnor, PA
Biosimulation company whose Evidence, Value & Access division provides HEOR consulting, global value dossiers, HTA health economic analyses, and market access strategy, alongside its modeling software business.
- HEOR consulting & modeling
- Global value dossiers
- HTA submissions analytics
- Value strategy
- RWE services
-
Boston, MA
Publicly traded economic and management consulting firm whose life sciences practice focuses on pricing, market access, HEOR/value framing, and policy analysis. Strong fit for high-value, policy-sensitive categories such as rare disease, oncology, and cell and gene therapy.
- Pricing & market access strategy
- Value & HEOR framing
- Policy & economic analysis
- Commercialization strategy
- Litigation-sensitive strategy
-
Newton, MA
Boutique life sciences strategy consultancy founded in Boston in 2007, advising biopharma on growth strategy including pricing and market access, asset strategy, and launch planning. More than half of consultants hold life sciences PhDs.
- Pricing & market access strategy
- Asset & portfolio strategy
- Launch planning
- Market entry strategy
-
Health economics consultancy partnering with biopharma companies to plan, generate, and execute HEOR strategies through economic modeling, real-world data, evidence synthesis, and digital health strategy.
- Economic modeling
- HEOR strategy
- Evidence synthesis
- Real-world data analysis
-
Milwaukee, WI
Global commercialization services platform for life sciences whose EVERSANA Deploy offering provides outsourced field sales, field reimbursement, and clinical educator teams, alongside integrated launch, market access, agency, and patient services capabilities. Positions itself as a full-service alternative to assembling multiple launch vendors.
- field team deployment
- contract sales
- launch commercialization services
- management consulting
- channel and distribution management
- patient services
-
Bethesda, MD
HEOR, market access, and real-world evidence consultancy operating as part of PPD (Thermo Fisher Scientific). Provides health economics modeling, payer evidence strategy, and market access consulting across all major therapeutic areas.
- Health economics & modeling
- Market access consulting
- Payer research
- Patient-centered outcomes
- RWE consulting
-
Hoboken, NJ
Tech-enabled RWE and HEOR consultancy founded in 2009, supporting life sciences companies with HEOR strategy, market access and value strategy, economic modeling, and evidence synthesis from offices in Hoboken, NJ and Newcastle, UK.
- HEOR consulting
- Market access & value strategy
- Economic modeling
- Evidence synthesis
- Payer research (RPR platform)
-
Newton, MA
Healthcare strategy consultancy founded in 1992 focused exclusively on life sciences and medtech, covering commercialization, market access, and reimbursement planning for biopharma, device, and diagnostics clients.
- Market access & reimbursement strategy
- Commercialization strategy
- Portfolio planning
- Corporate growth strategy
-
Yardley, PA
Life sciences commercialization consultancy guiding pharma and biotech companies from early asset strategy through launch execution, with practices in launch planning, marketing, market access, and medical affairs, and hands-on launch operations support for emerging biopharma.
- launch planning and readiness
- brand and marketing strategy
- commercial operations support
- market access strategy
- medical affairs consulting
-
Dublin, Ireland
Global CRO with a dedicated pricing, market access, and reimbursement consulting practice (ICON Access, Commercialisation & Communications) of 300+ experts. Supports payer strategy, HTA submissions, HEOR, and value communications.
- Pricing & market access strategy
- HTA submissions
- HEOR
- Payer research
- Value communications
-
Life sciences consultancy focused on market access, ICER/HEOR support, large-scale data analytics, modeling, forecasting, and market opportunity evaluation, with experience in over 30 countries.
- Market access strategy
- ICER & HEOR support
- Forecasting & modeling
- Data analytics
-
Durham, NC
Global human data science company whose prescription and sales datasets (National Prescription Audit, National Sales Perspectives, LRx longitudinal prescription data, Xponent) are the industry standard for measuring US pharmaceutical demand. Its commercial analytics platform supports HCP targeting, launch tracking, and omnichannel engagement for pharma.
- National Prescription Audit (NPA)
- longitudinal prescription data (LRx)
- national sales data (NSP)
- commercial analytics and HCP targeting
- launch analytics
- specialty pharmacy data integration
-
Washington, DC
Healthcare growth strategy consultancy founded in 2019 as a spin-off from Kaiser Associates, serving pharma, biotech, medtech, and digital health clients with commercial strategy including pricing and market access.
- Pricing & market access strategy
- Commercial strategy
- Commercial due diligence
- Go-to-market strategy
-
Boston, MA / London, UK
Global strategy consultancy with a dedicated biopharma pricing and market access practice. Helps clients assess commercial viability of pipeline assets, define pricing and reimbursement pathways, and build launch strategies.
- Pharmaceutical pricing strategy
- Market access strategy
- Reimbursement assessment
- Launch strategy
- Commercial due diligence
-
Healthcare consultancy formed in 2022 by Arsenal Capital Partners from the merger of Cello Health, BresMed, Guidemark Health, Cyan Health, and Zipher Medical Affairs. Strong in value demonstration, HEOR modeling, value dossiers, and HTA submissions.
- HEOR & economic modeling
- Value dossiers & HTA submissions
- Market access strategy
- Evidence generation
- Medical affairs & communications
-
Washington, DC
Boutique market access, HEOR, and healthcare policy consultancy serving pharmaceutical companies, device manufacturers, and trade associations. Helps clients overcome payer barriers, secure reimbursement, and accelerate patient access.
- Market access strategy
- HEOR
- Healthcare policy consulting
- Reimbursement strategy
-
New York, NY
Global strategic HEOR and market access consultancy founded in 2015, headquartered in New York City. Supports pharma, biotech, and medical device clients across all phases of asset development with value proposition and evidence strategy.
- HEOR strategy
- Value proposition development
- Evidence gap analysis
- Payer tools & health economics training
-
New York, NY
Omnicom Health's unified market access division, formed in 2025 from Entrée Health (a payer/access communications agency since 1997), McCann Health Managed Markets, Mosaic Group, Valuate Health Consultancy, and Archbow Consulting.
- Access & reimbursement communications
- Value propositions & HEOR communications
- Pricing & contracting strategy
- Pull-through & payer marketing
-
London, UK (major US operations)
Global HEOR, market access, and medical communications group established in 2011, significantly expanded through its 2020 merger with HEOR firm Pharmerit International. Serves biopharma with evidence generation, value communication, and access strategy.
- Market access strategy
- HEOR & economic modeling
- Value dossiers & HTA submissions
- Payer evidence & communications
- Medical communications
-
Morristown, NJ
Analytics-led market access agency and consultancy founded in 2009, headquartered in Morristown, NJ. Combines behavioral analytics, access strategy consulting, and payer value communications for pharma and biotech clients.
- Payer decision analytics
- Access strategy consulting
- Value communications
- Market research & decision-support tools
-
Pharmaceutical commercialization platform formed in 2023 by Oak Hill Capital and Dan Renick, whose units Petauri Advisors, Petauri Evidence, and Petauri MAx deliver pricing and market access strategy, HEOR/value evidence, and payer engagement.
- Pricing & market access strategy
- Value demonstration & HEOR
- Payer research (Formulary Insights)
- Market access communications
-
Bethesda, MD
Market access business of Precision Medicine Group with 1,200+ dedicated market access and HEOR experts serving biopharma. Offers access strategy, pricing and contracting, value and access consulting, HEOR, and payer marketing.
- Access strategy
- Pricing & contracting strategy
- HEOR
- Value dossiers & HTA submissions
- Payer marketing
-
Boston, MA
Boston-based life sciences strategy consultancy founded in 1988, with core strength in pricing and market access, portfolio planning, and launch strategy for biopharma. Now part of Inizio Advisory.
- Pricing & market access strategy
- Launch planning
- Portfolio & commercial strategy
- Global HTA/payer strategy
-
Bonn, Germany
Global pricing strategy consultancy whose healthcare and life sciences division has advised pharma and biotech on pricing and market access for over 40 years. Works across strategy, marketing, sales, and pricing/market access throughout the product lifecycle.
- Global & US pricing strategy
- Market access strategy
- Reimbursement strategy
- Launch readiness
- Contracting strategy
-
New York, NY
US market access strategy consultancy founded in 2010, focused on oncology and specialty therapeutics. Services include payer and provider access strategy, clinical pathways strategy, and specialty channel strategy.
- Oncology/specialty access strategy
- Clinical pathways strategy
- Channel strategy
- Patient support strategy
-
Waltham, MA
Life sciences commercialization consultancy (founded 1996 as Trinity Partners) providing launch strategy, brand and commercial planning, field force sizing and design, analytics, and technology-enabled insights alongside its pricing and market access practice.
- launch and brand strategy
- commercial model and field force design
- forecasting and analytics
- pricing and market access
- commercial technology and data products
-
Powell, OH
Pharma services and strategic consulting firm helping pharmaceutical and biotech companies plan and execute product launches, spanning pre-launch planning, channel and distribution strategy, market access, and market intelligence across the full product life cycle.
- launch planning and execution
- commercialization strategy
- channel and trade strategy
- market intelligence
- market access consulting
-
New York, NY
Market access and reimbursement consultancy combining former payer and PBM executives with analytics to help manufacturers develop and execute value strategies. Part of Omnicom Health Market Access.
- Reimbursement potential assessment
- Value platform development
- Payer/PBM strategy
- Health policy response strategy
-
Raleigh, NC
Medtech- and diagnostics-focused service provider whose commercial strategy and market access practice (built on Boston Healthcare Associates) covers pricing, reimbursement, and market access strategy for devices and IVDs.
- Device/diagnostic reimbursement strategy
- Pricing & market access
- Evidence & value strategy
- Commercialization strategy
-
Evanston, IL
Global professional services firm founded in 1983 by Northwestern Kellogg professors Andris Zoltners and Prabhakant Sinha, historically the market leader in pharmaceutical sales force sizing, territory alignment, incentive compensation, and commercial analytics, now spanning AI-enabled commercial transformation.
- sales force design and sizing
- territory alignment
- incentive compensation management
- commercial analytics and AI
- launch and go-to-market strategy
- commercial operations outsourcing
